Applications and reference implementations demonstrating how to build AI-powered solutions with Oracle technologies. These complete, working examples showcase end-to-end implementations of AI ...

Oracle's strong AI growth fuels investor interest in its booming cloud computing sector. Anyone can buy Oracle shares through a brokerage using specific order details. Oracle aims for double-digit ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A St. Louis developer behind ...

Oracle's stock has tumbled 30% so far this quarter, headed for its steepest drop since the third quarter of 2001, when it slid almost 34%. Investors have grown skeptical about Oracle's ability to open ...

The AI arms race is heating up, and its effects are starting to show up where investors actually care – on the Big Tech balance sheets. According to UBS, global AI capex is now expected to hit $423 ...

Wall Street’s major indexes closed lower on Friday, and investors left technology for other sectors as Broadcom and Oracle fueled concerns about an AI bubble and rising U.S. Treasury yields added ...

An upbeat second-quarter earnings report from Oracle wasn’t enough to shake off the artificial-intelligence jitters that have crept into the stock. Oracle ORCL cleared the bar set by Wall Street on ...

Dec 10 (Reuters) - Oracle forecast sales and profit that missed ‌analyst estimates on Wednesday, while saying that spending would rise ‌by $15 billion compared with earlier estimates - a sign that big ...

Google says hackers associated with a prolific ransomware group are sending extortion emails to executives at “numerous” large organizations after claiming to have stolen their sensitive information ...

Michael Bromberg is a finance editor with a decade of experience. He is an expert at elucidating complex financial topics in clear, concise language. Michael received a Bachelor of Arts in literature ...

Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the works. Longtime drug developer Suma Krishnan was in ...